Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979678642> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2979678642 endingPage "905" @default.
- W2979678642 startingPage "905" @default.
- W2979678642 abstract "Multidrug resistance (MDR) is one of the major factors which contributes to the failure of cancer chemotherapy treatment, and because of MDR, numerous efforts have been made to overcome it in the recent years. To identify novel MDR inhibitors, we developed a 96-well plate high-throughput cell-based screening assay. Using this assay on the National Cancer Institute Diversity Set Library, we identified tetradrine (NSC77037), a small molecular compound that, reverses MDR1 (Pgp) but not MRP or BCRP-mediated MDR in multidrug resistant cell lines derived from human tumors. The ability to reverse MDR is comparable to that of frequently used reversal agents such as verapamil and CsA. Cytotoxic activity of tetradrine was evaluated in vitro using human sarcoma and ovarian, breast, and colon cancer cell lines expressing various levels of Pgp, as well as using a lung cancer cell line expressing MRP and a breast cancer cell line expressing BCRP. From these results, we found that tetradrine itself at concentration >10µM moderately inhibits the proliferation of both sensitive and resistant cells with almost equal activity, but its inhibitory effect is not altered by co-incubation with verapamil, suggesting that tetradrine may not be a substrate of Pgp. Additionally, tetradrine increases the intracellular accumulation of Pgp substrates: Calcein AM, Rhodamine-123, paclitaxel, mitoxantrone, and doxorubicin, by enhancing the uptake and/or decreasing the efflux of these compounds in resistant cells. Finally, we are also able to show that tetradrine directly inhibiting the function of Pgp in a dose-dependent manner. In contrast, tetradrine does not inhibit the total expression level of Pgp. These results indicate that tetradrine is capable of reversing MDR in many cancer cells to chemotherapeutic agents by directly inhibiting the function of Pgp. The ability of tetradrine to restore sensitivity to drug therapy or to prevent resistance could potentially benefit a large number of cancer patients. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 905." @default.
- W2979678642 created "2019-10-18" @default.
- W2979678642 creator A5014323068 @default.
- W2979678642 creator A5038077156 @default.
- W2979678642 creator A5055817420 @default.
- W2979678642 creator A5071532449 @default.
- W2979678642 creator A5077134715 @default.
- W2979678642 creator A5082130171 @default.
- W2979678642 date "2009-05-01" @default.
- W2979678642 modified "2023-09-24" @default.
- W2979678642 title "Abstract #905: The small molecule Tetradrine (NSC77037), identified in a high-throughput cell-based screen, reverses multidrug resistance in cancer cells" @default.
- W2979678642 hasPublicationYear "2009" @default.
- W2979678642 type Work @default.
- W2979678642 sameAs 2979678642 @default.
- W2979678642 citedByCount "0" @default.
- W2979678642 crossrefType "journal-article" @default.
- W2979678642 hasAuthorship W2979678642A5014323068 @default.
- W2979678642 hasAuthorship W2979678642A5038077156 @default.
- W2979678642 hasAuthorship W2979678642A5055817420 @default.
- W2979678642 hasAuthorship W2979678642A5071532449 @default.
- W2979678642 hasAuthorship W2979678642A5077134715 @default.
- W2979678642 hasAuthorship W2979678642A5082130171 @default.
- W2979678642 hasConcept C114851261 @default.
- W2979678642 hasConcept C121608353 @default.
- W2979678642 hasConcept C126322002 @default.
- W2979678642 hasConcept C133936738 @default.
- W2979678642 hasConcept C185592680 @default.
- W2979678642 hasConcept C200082930 @default.
- W2979678642 hasConcept C2776694085 @default.
- W2979678642 hasConcept C2777022698 @default.
- W2979678642 hasConcept C2777292972 @default.
- W2979678642 hasConcept C2778589691 @default.
- W2979678642 hasConcept C2780923524 @default.
- W2979678642 hasConcept C2781303535 @default.
- W2979678642 hasConcept C502942594 @default.
- W2979678642 hasConcept C519063684 @default.
- W2979678642 hasConcept C54355233 @default.
- W2979678642 hasConcept C55493867 @default.
- W2979678642 hasConcept C71924100 @default.
- W2979678642 hasConcept C81885089 @default.
- W2979678642 hasConcept C86803240 @default.
- W2979678642 hasConcept C89423630 @default.
- W2979678642 hasConcept C96232424 @default.
- W2979678642 hasConcept C98274493 @default.
- W2979678642 hasConceptScore W2979678642C114851261 @default.
- W2979678642 hasConceptScore W2979678642C121608353 @default.
- W2979678642 hasConceptScore W2979678642C126322002 @default.
- W2979678642 hasConceptScore W2979678642C133936738 @default.
- W2979678642 hasConceptScore W2979678642C185592680 @default.
- W2979678642 hasConceptScore W2979678642C200082930 @default.
- W2979678642 hasConceptScore W2979678642C2776694085 @default.
- W2979678642 hasConceptScore W2979678642C2777022698 @default.
- W2979678642 hasConceptScore W2979678642C2777292972 @default.
- W2979678642 hasConceptScore W2979678642C2778589691 @default.
- W2979678642 hasConceptScore W2979678642C2780923524 @default.
- W2979678642 hasConceptScore W2979678642C2781303535 @default.
- W2979678642 hasConceptScore W2979678642C502942594 @default.
- W2979678642 hasConceptScore W2979678642C519063684 @default.
- W2979678642 hasConceptScore W2979678642C54355233 @default.
- W2979678642 hasConceptScore W2979678642C55493867 @default.
- W2979678642 hasConceptScore W2979678642C71924100 @default.
- W2979678642 hasConceptScore W2979678642C81885089 @default.
- W2979678642 hasConceptScore W2979678642C86803240 @default.
- W2979678642 hasConceptScore W2979678642C89423630 @default.
- W2979678642 hasConceptScore W2979678642C96232424 @default.
- W2979678642 hasConceptScore W2979678642C98274493 @default.
- W2979678642 hasLocation W29796786421 @default.
- W2979678642 hasOpenAccess W2979678642 @default.
- W2979678642 hasPrimaryLocation W29796786421 @default.
- W2979678642 hasRelatedWork W1511437596 @default.
- W2979678642 hasRelatedWork W1939597407 @default.
- W2979678642 hasRelatedWork W1973708766 @default.
- W2979678642 hasRelatedWork W1978032094 @default.
- W2979678642 hasRelatedWork W2009001415 @default.
- W2979678642 hasRelatedWork W2042119327 @default.
- W2979678642 hasRelatedWork W2072731290 @default.
- W2979678642 hasRelatedWork W2082393330 @default.
- W2979678642 hasRelatedWork W2122754213 @default.
- W2979678642 hasRelatedWork W2131909571 @default.
- W2979678642 hasRelatedWork W2138138876 @default.
- W2979678642 hasRelatedWork W2156088967 @default.
- W2979678642 hasRelatedWork W2409511973 @default.
- W2979678642 hasRelatedWork W2553899195 @default.
- W2979678642 hasRelatedWork W2605470475 @default.
- W2979678642 hasRelatedWork W2739601308 @default.
- W2979678642 hasRelatedWork W2885472956 @default.
- W2979678642 hasRelatedWork W2891790470 @default.
- W2979678642 hasRelatedWork W2980693920 @default.
- W2979678642 hasRelatedWork W3092285225 @default.
- W2979678642 hasVolume "69" @default.
- W2979678642 isParatext "false" @default.
- W2979678642 isRetracted "false" @default.
- W2979678642 magId "2979678642" @default.
- W2979678642 workType "article" @default.